08/20/2024 7:16 PM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2024 7:42 PM | BridgeBio Pharma (Subject) VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
08/20/2024 5:24 PM | BridgeBio Pharma (Issuer) Trimarchi Thomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 5:27 PM | BridgeBio Pharma (Issuer) STEPHENSON BRIAN C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 5:31 PM | BridgeBio Pharma (Issuer) Kumar Neil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 3:27 PM | BridgeBio Pharma (Subject) Kumar Neil (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024 3:29 PM | BridgeBio Pharma (Subject) STEPHENSON BRIAN C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/08/2024 3:39 PM | BridgeBio Pharma (Issuer) Trimarchi Thomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 4:06 PM | BridgeBio Pharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2024 6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/29/2024 7:16 PM | BridgeBio Pharma (Issuer) Trimarchi Thomas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/23/2024 3:12 PM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:38 PM | BridgeBio Pharma (Issuer) HOMCY CHARLES J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:38 PM | BridgeBio Pharma (Issuer) Lo Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:39 PM | BridgeBio Pharma (Issuer) MCCORMICK FRANK (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:39 PM | BridgeBio Pharma (Issuer) Ellis Andrea (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:39 PM | BridgeBio Pharma (Issuer) Hassan Fred (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:39 PM | BridgeBio Pharma (Issuer) MOMTAZEE JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:40 PM | BridgeBio Pharma (Issuer) Satvat Ali J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:42 PM | BridgeBio Pharma (Issuer) Scott Randal W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:42 PM | BridgeBio Pharma (Issuer) Valantine Hannah (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:34 PM | AGUIAR ERIC (Reporting) BridgeBio Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:35 PM | BridgeBio Pharma (Issuer) Cook Jennifer E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:36 PM | BridgeBio Pharma (Issuer) Dachille Douglas A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:36 PM | BridgeBio Pharma (Issuer) DANIELS RONALD J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 5:01 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2024 3:53 PM | BridgeBio Pharma (Issuer) Scott Randal W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:13 PM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:15 PM | BridgeBio Pharma (Filer)
| Form 424B5 | |
03/04/2024 6:00 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 6:15 PM | BridgeBio Pharma (Subject) Kumar Neil (Filed by)
| Form SC 13G/A | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) BridgeBio Pharma (Subject)
| Form SC 13G/A | |
01/23/2024 9:16 AM | BridgeBio Pharma (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 3:10 PM | BridgeBio Pharma (Issuer) Valantine Hannah (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 6:30 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 4:14 PM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2023 4:33 PM | BridgeBio Pharma (Subject) MCCORMICK FRANK (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023 3:15 PM | BridgeBio Pharma (Subject) Scott Randal W. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:20 PM | BridgeBio Pharma (Subject) Scott Randal W. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9365&Placement=NativeDisplay&Source=NativeDisplay) Claim Exclusive 100% Bonus: $0.25/Share |
11/22/2023 3:15 PM | BridgeBio Pharma (Subject) VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
11/17/2023 3:27 PM | BridgeBio Pharma (Subject) Kumar Neil (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023 3:27 PM | BridgeBio Pharma (Subject) STEPHENSON BRIAN C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023 3:03 PM | BridgeBio Pharma (Subject) Valantine Hannah (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2023 3:00 PM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 3:00 PM | BridgeBio Pharma (Issuer) Scott Randal W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |